HDAC9 and muscular dystrophy: A recent study has revealed that histone deacetylase (HDAC) inhibitors provide a promising route to treat muscular dystrophy in murine models via the induction of follistatin in interstitial muscle cells consistent with our results here showing that muscle mass is regulated by complex interactions between multiple cells types (Mozzetta et al., 2013).